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Summary
Background: Chronic liver disorders represent a serious health problem. Nitric oxide (NO)
synthesized by inducible nitric oxide synthase (iNOS) can function as an antimicrobial agent
able to kill or reduce replication of microorganisms, and plays an important role in immune
regulation. This study was undertaken to evaluate the expression of iNOS in chronic viral hepatitis
and its relation to histopathology.
Methods: This study included 56 patients with chronic viral hepatitis (38 hepatitis B, 18 hepatitis
C). There were 35 men and 21 women with a mean age of 38.6  21.731 years. A modified form of
the histology activity index (HAI) designed by Ishak and colleagues was used to assess grading and
staging of chronic viral hepatitis. The needle biopsy specimens were fixed in 10% formalin and
routinely processed. Routine hematoxylin—eosin, periodic acid—Schiff, and reticulin staining,
and iNOS immunoperoxidase technique were performed on paraffin-embedded tissues.
Results: We demonstrated that all liver samples had a marked iNOS expression, with a diffuse
distribution pattern. iNOS consistently labeled mononuclear cells infiltrating portal tracts in all
samples. Statistical evaluation of data showed that the iNOS expression correlated with the HAI
and fibrosis. Furthermore a correlation between iNOS and severity of disease was detected
(r = 0.772, p = 0.000).
Conclusions: Further investigations are required to determine whether iNOS-related treatment
protocols could be useful in reducing disease severity.
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Chronic liver disorders represent a serious health problem,
especially considering that 300 million people worldwide
are hepatitis B virus carriers and that in the USA alone,
8000—10 000 patients die every year as a result of liverPublished by Elsevier Ltd. All rights reserved.
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Figure 2 iNOS immunoexpression with a diffuse distribution
pattern throughout the hepatic lobules and monocytes (iNOS
200).
Figure 1 iNOS positive stained hepatocytes with steatosis and
interface hepatitis in a case of severe chronic hepatitis (iNOS
400).failure caused by hepatitis C.1,2 An epidemiological and
clinical association between either hepatitis B virus (HBV)
or hepatitis C virus (HCV) infections and the development of
chronic hepatitis and the appearance of hepatocellular car-
cinoma is currently evident.3—5 The role of prolonged cellular
damage such as in viral or bacterial infection-related chronic
inflammation has become widely recognized.3—5 In humans
hepatocellular carcinomas are usually associated with viral
hepatitis B and C and cirrhosis resulting from chronic hepa-
titis.5 Much less is known about nitric oxide synthase (NOS)
function in the human liver; human inducible nitric oxide
synthase (iNOS) was first cloned from human hepatocytes in
culture.1
One of the major mediators in chronic inflammatory
processes is nitric oxide (NO), which is produced by liver
parenchymal and non-parenchymal cells from L-arginine via
NOS.3,5,6 NO is considered to exert a hepatoprotective action
against tissue injury and cytotoxic effects due to invading
microorganisms, parasites and tumor cells.2,5 However any
situation that causes uncontrolled, prolonged and/ormassive
production of NO by iNOS may result in liver damage, leading
to inflammation and even tumor development.5
Mihm et al. have found that the hepatic expression of iNOS
in chronic hepatitis C is positively related to the hepatic viral
load and liver injury.7 A long-term overproduction of iNOS-
generated NO may mediate important pathogenic events in
the course of chronic viral hepatitis (CVH).3 We aimed to
demonstrate the histopathological correlation with immu-
noexpression of iNOS in chronic viral hepatitis.
Materials and methods
This study included 56 patients with CVH (38 hepatitis B, 18
hepatitis C). A modified form of the histology activity index
(HAI) designed by Ishak and colleagues was used to assess
grading and staging of the CVH.8 There were 35 men and 21
women with a mean age of 38.6  21.731 years (age range
3—75).
Liver biopsy specimens from CVH patients were
obtained using a Menghini needle by percutaneous route.
The needle biopsy specimens were fixed in 10% formalin
and routinely processed. Routine hematoxylin—eosin, per-
iodic acid—Schiff, and reticulin staining were performed
on paraffin-embedded tissues. These case slides were
reviewed, and the immunoperoxidase technique was per-
formed with iNOS monoclonal antibody to selected sections
from each case.
Immunohistochemical staining was carried out by depar-
affinization, dehydration, and incubation in citrate buffer.
Single antigen staining was performed with iNOS protein
(monoclonal, biotinylated goat anti-rabbit) and Ultravision
Polyvalent, HRP-AEC kit (Neomarkers-Biogen, Lab Vision,
USA). A labeled streptavidin—biotin—peroxidase (immunoen-
zymatic) antigen detection system and AEC chromogen were
used. For the evaluation of iNOS, positive stained cells were
counted in five different areas at a magnification 40 using
an Olympus BX51 microscope in each case. The mean
values were calculated. iNOS expression was independently
recorded by two pathologists and the results were averaged.
The local medical ethics committee approval for the study
was obtained, and all patients included in the study gave
informed consent.Statistical procedures were carried out using the software
of Epi INFO version 3.3.2 (CDC, The Centers for Disease
Control and Prevention, USA) and a p-value <0.05 was
considered statistically significant. For comparison of the
findings, Spearman’s correlation test was performed.
Results
The chronic hepatitis cases were classified as mild chronic
hepatitis (1), moderate chronic hepatitis (36), and severe
chronic hepatitis (19), according to the Ishak scoring system.
We demonstrated that all liver samples from patients with
either chronic hepatitis B (CHB) or chronic hepatitis C (CHC)
had a marked iNOS expression, with a diffuse distribution
pattern throughout the hepatic lobules, which is consistent
with the literature.3,4,9 Hepatocellular positive iNOS staining
was mainly cytoplasmic (Figures 1 and 2). The mean immu-
noexpression value of iNOS was 45.17  19.702. The distri-
bution of iNOS in CHB exhibited an almost identical pattern
to that in CHC. Furthermore iNOS consistently labeled
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Figure 3 Collections of inflammatory cells positive stained by
iNOS in a portal area (iNOS 400).mononuclear cells infiltrating portal tracts in all samples
(Figure 3). No iNOS induction was observed in normal liver
samples.
Statistical evaluation of data showed that the iNOS
expression correlated with the HAI and fibrosis (Table 1).
There was a positive correlation with iNOS positivity and
patient age (r = 0.47, p < 0.001), but there was no correla-
tion between iNOS immunopositivity and gender. Further-
more a correlation between iNOS immunoexpression and
severity of disease was detected (r = 0.772, p = 0.000).
Discussion
It is conceivable that in the intrahepatic microenvironment
of CVH an important source of NO exists.3,9 Since a marked
induction of iNOS expression is observed in the majority of
hepatocytes from patients with CVH, it is likely that these
liver cells are a powerful cellular source of large quantities of
NO.1,3,9
In CVH, it has been suggested that the viral infection
itself, by mechanisms not yet fully understood, may be a
triggering factor.9 It could be suggested that this nitrationTable 1 Bivariate correlations between iNOS, severity of disease
Severity o
iNOS Correlation coefficient 0.772b
Sig. (two-tailed) 0.000
N 56
Severity of disease Correlation coefficient
Sig. (two-tailed)
N
HAI Correlation coefficient
Sig. (two-tailed)
N
Fibrosis Correlation coefficient
Sig. (two-tailed)
N
iNOS, inducible nitric oxide synthase; HAI, histology activity index. N
a Correlation is significant at the 0.05 level (two-tailed).
b Correlation is significant at the 0.01 level (two-tailed).process represents a non-specific pathogenic mechanism,
common to different chronic inflammatory diseases and sec-
ondary to the elicitation of inflammation rather than its
cause.3,9 Many studies have identified several risk factors such
as age, gender, immune status, viral factors, alcohol consump-
tion, cigarette smoking, exposure to aflatoxin, and viral super-
infection as causes of liver disease progression.10,11 We also
found a positive correlation with iNOS positivity and patient
age (r = 0.47, p < 0.001), but there was no correlation
between iNOS immunopositivity and gender in our study.
Smoking increases the production of pro-inflammatory
cytokines (interleukin (IL)-1, IL-6 and tumor necrosis fac-
tor-a (TNFa)) that are involved in liver cell injury and affect
both cell-mediated and humoral immune responses.12 iNOS
can also be induced by TNFa and interferon-g (IFNg) in many
immune cells. These pathways may contribute to the patho-
biology of Th1-mediated liver injuries.6,8
Disturbance of the hepatocellular oxidant—antioxidant
balance may contribute to the pathogenesis of progressive
liver damage in chronic viral liver disease.3,9
High concentrations of NO are generated by iNOS, which is
expressed in activated macrophages and in hepatocytes.3,6
We demonstrated that all liver samples from patients with
either CHB or CHC had a marked iNOS expression, with a
diffuse distribution pattern throughout the hepatic lobules,
consistent with the literature.3,4,9 Furthermore iNOS consis-
tently labeled mononuclear cells infiltrating portal tracts in
all our samples.
Intracellular pathogens are shielded from host extracel-
lular defenses by the cell membrane. NO, a gaseous radical,
readily diffuses across this membrane. It appears to play a
significant role in the clearance of intracellular pathogens
and may also be of potential importance in some viral
infections.6,13 The protective function of NO in liver inflam-
mation, probably related to its anti-apoptotic capacity,
needs further investigation.9
NO, a small potent lipophilic gas with different biological
activities, has important roles in modulating tissue injury and
carcinogenesis.6,13 Three distinct forms of NOS catalyze the
formation of NO.10 NO synthesized by iNOS can function as an
antimicrobial agent able to kill or reduce replication of
viruses, bacteria or protozoa, and plays an important role, HAI, and fibrosis with Spearman’s correlation analysis
f disease HAI Fibrosis Age of patient
0.816b 0.439b 0.473b
0.000 0.001 0.000
56 56 56
0.821b 0.588b 0.276a
0.000 0.000 0.040
56 56 56
0.582b 0.384b
0.000 0.003
56 56
0.281a
0.036
56
= number of the patients.
iNOS and histopathology of viral hepatitis 15in immune regulation.2 The trigger mechanism for iNOS
induction in CHC is not known.9 It has also been shown that
hepatitis B surface antigen induces iNOS in cultured hepato-
cytes, which may play a role in hepatocarcinogenesis.5 iNOS
may contribute to tumor promotion via NO production and
the subsequent action of peroxynitrite.5 NO has a role in host
defense in the normal liver,5 but may act in cancer promotion
by stimulating aberrant differentiation of the cells and
angiogenesis, and inducing tissue DNA damage.5
In this study, we have demonstrated that chronic liver
disease is associated with an enhanced intrahepatic iNOS
expression, which promotes increased synthesis of NO. More-
over, we have shown that NO-mediated nitration of hepato-
cellular proteins is substantially induced in the inflamed liver
tissue from patients with CVH. This phenomenon correlated
with the HAI and fibrosis. In chronic hepatitis infection
the iNOS expression was found to correlate to the disease
severity.
Further prospective investigations are required to deter-
mine whether iNOS-related treatment protocols could be
useful in reducing disease severity and whether they could
be beneficial in the antiviral treatment of some patients with
CVH.
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